Genotype-phenotype relationships of presenilin-1 mutations in alzheimer's disease: An update

Journal of Alzheimer's Disease

Volumn 17, Issue 2, 2009, Pages 259-265

  Larner, Andrew J ^a   Doran, Mark ^a  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Alzheimer's disease; Presenilin 1

Indexed keywords

PRESENILIN 1;

ALZHEIMER DISEASE; CHROMOSOME 14; DEGENERATIVE DISEASE; GENE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; NEUROPATHOLOGY; PRIORITY JOURNAL; PSEN1 GENE; REVIEW;

EID: 67849085401     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2009-1042     Document Type: Review

References (61)

1. Larner AJ, Doran M (2006) Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene. J Neurol 253, 139-158.
2. Van Duijn CM, Cruts M, Theuns J, Van Gassen G, Backhovens H, van den Broeck M, Wehnert A, Serneels A, Hofman A, Van Broeckhoven C (1999) Genetic association ofthe presenilin-1 regulatory region with early-onset Alzheimer's disease in a population-based sample. Eur J Hum Genet 7, 801-806.
3. Pandey P, Pradhan S, Mittal B (2007) Presenilin gene predisposes to late-onset degenerative but not vascular dementia: a comparative study of PS1 and ApoE genes in a North Indian cohort. Dement Geriatr Cogn Disord 24, 151-161.
4. AGS Ethics Committee (2001) Genetic testing for late-onset Alzheimer's disease. JAGS 49, 225-226.
5. Raux G, Guyant-Marechal L, Martin C, Bou J, Penet C, Brice A, Hannequin D, Frebourg T, Campion D (2005) Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update. JMed Genet 42, 793-795.
6. Guerreiro RJ, Baquero M, Blesa R, Boada M, Bras JM, Bulli- do MJ, Calado A, Crook R, Ferreira C, Frank A, Gomez-Isla T, Hernandez I, Lleo A, Machado A, Martinez-Lage P, Mas- deu J, Molina-Porcel L, Molinuevo JL, Pastor P, Perez-Tur J, Relvas R, Oliveira CR, Ribeiro MH, Rogaeva E, Sa A, Samaranch L, Sanchez-Valle R, Santana I, Tarraga L, Valdivieso F, Singleton A, Hardy J, Clarimon J (2009) Genetic screening ofAlzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP. Neurobiol Aging, in press.
7. Golan MP, Styczynska M, Jozwiak K, Walecki J, Maruszak A, Pniewski J, Lugiewicz R, Filipek S, Zekanowski C, Bar- cikowska M (2007) Early-onset Alzheimer's disease with a de novo mutation in the presenilin 1 gene. Exp Neurol 208, 264-268.
8. Piccini A, Zanusso G, Borghi R, Noviello C, Monaco S, Rus- so R, Damonte G, Armirotti A, Gelati M, Giordano R, Zam- benedetti P, Russo C, Ghetti B, Tabaton M (2007) Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype. Arch Neurol 64, 738-745.
9. Snider BJ, Norton J, Coats MA, Chakraverty S, Hou CE, Jervis R, Lendon CL, Goate AM, McKeel Jr DW, Morris JC (2005) Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade oflife. Arch Neurol 62, 1821-1830.
10. Edwards-Lee T, Wen J, Bell J, Hardy J, Chung J, Momeni P (2006) A presenilin-1 mutation (T245P) in transmembrane domain 6 causes early onset Alzheimer's disease. Neurosci Lett 398, 251-252.
11. Karlstrom H, Brooks WS, Kwok JB, Broe GA, Kril JJ, Mc- Cann H, Halliday GM, Schofield PR (2008) Varaible pheno- type of Alzheimer's disease with spastic paraparesis. J Neu- rochem 104, 573-583.
12. Matsubara-Tsutsui M, Yasuda M, Yamagata H, Nomura T, Taguchi K, Kohara K, Miyoshi K, Miki T (2002) Molecular evidence of presenilin 1 mutation in familial early onset dementia. Am J Med Genet 114, 292-298.
13. Akatsu H, Yamagata H, Wake A, Watanabe I, Kimura N, Ka- mada K, Miyazaki T, Tanabe H, Miki T, Yamamoto T, Hori A, Mimuro M, Yoshida M, Hashizume Y (2008) The first autopsy case report of familial Alzheimer's disease associated with a mutation at G266S in the presenilin 1 gene. Alzheimers Dement 4 (suppl 2), T578.
14. Dumanchin C, Tournier I, Martin C, Didic M, Belliard S, Car- lander B, Rouhart F, Duyckaerts C, Pellissier JF, Latouche JB, Hannequin D, Frebourg T, Tosi M, Campion D (2006) Biological effects offour PSEN1 gene mutations causing Alzheimer disease with spastic paraparesis and cotton wool plaques. Hum Mutat 27, 1063.
15. Bernardi L, Tomaino C, Anfossi M, Gallo M, Geracitano S, Costanzo A, Colao R, Puccio G, Frangipane F, Curcio SA, Mirabelli M, Smirne N, Iapaolo D, Maletta RG, Bruni AC (2009) Novel PSEN1 and PGRN mutations in early-onset familial frontotemporal dementia. Neurobiol Aging, in press.
16. Larner AJ, Doran M (2006) Reply to Dr. Raux et al.: Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update (J Med Genet 2005; 42:793-5). J Med Genet 43, e44.
17. Finckh U, Kuschel C, Anagnostouli M, Patsouris E, Pantes GV, Gatzonis S, Kapaki E, Davaki P, Lamszus K, Stavrou D, Gal A (2005) Novel mutations and repeated findings of mutations in familial Alzheimer disease. Neurogenetics 6, 85-89.
18. Knight WD, Kennedy J, Mead S, Rossor MN, Beck J, Collinge J, Mummery C (2007) A novel presenilin 1 deletion (p.L166del) associated with early onset familial Alzheimer's disease. Eur J Neurol 14, 829-831.
19. Pantieri R, Pardini M, Cecconi M, Dagna-Bricarelli F, Vitali A, Piccini A, Russo R, Borghi R, Tabaton M (2005) A novel presenilin 1L166H mutation in apseudosporadic case of early- onset Alzheimer's disease. Neurol Sci 26, 349-350.
20. Goldman JS, Miller BL, Safar J, de Tourreil S, Martindale JL, Prusiner SB, Geschwind MD (2004) When sporadic disease is not sporadic: the potential for genetic aetiology. Arch Neurol 61, 213-216.
21. Anheim M, Hannequin D, Boulay C, Martin C, Campion D, Tranchant C (2007) Ataxic variant of Alzheimer's disease caused by Pro117Ala PSEN1 mutation. J Neurol Neurosurg Psychiatry 78, 1414-1415.
22. Kauwe JSK, Wang J, Chakraverty S, Goate AM, Henao- Martinez AF (2008) Novel presenilin 1 variant (P117A) causing Alzheimer's disease in the fourth decade oflife. Neurosci Lett 438, 257-259.
23. Raman A, Lin X, Suri M, Hewitt M, Constantinescu CS,Phillips MF (2007) A presenilin 1 mutation (Arg278Ser) associated with early onset Alzheimer's disease and spastic para- paresis. J Neurol Sci, 260, 78-82.
24. Marrosu MG, Floris G, Costa G, Schirru L, Spinicci G, Cher- chi MV, Mura M, Mascia MG, Cocco E (2006) Dementia, pyramidal system involvement, and leukoencephalopathy with a presenilin 1 mutation. Neurology 66, 108-111.
25. Wu K, Lane R, Perry R, Festenstein R, Vaughan J (2009) A novel presenilin 1 mutation (Leu286Arg) in early onset Alzheimer's disease with spastic paraparesis. JNeurol Neuro- surg Psychiatry 80, 115.
26. Sánchez-Valle R, Lladó A, Ezquerra M, Rey MJ, Rami L, Molinuevo JL (2007) A novel mutation in the PSEN1 gene (L286P) associated with familial early-onset dementia of Alzheimer type and lobar haematomas. Eur JNeurol 14, 1409-1412.
27. Klünemann HH, Rogaeva E, Neumann M, Kretzschmar HA, Kandel M, Toulina A, Sato C, Salehi-Rad S, Pfister K, Klein HE, St George-Hyslop PH (2004) Novel PS1 mutation in a Bavarian kindred with familial Alzheimer disease. Alzheimer Dis Assoc Disord 18, 256-258
28. Zekanowski C, Golan MP, Krzysko KA, Lipczynska- Lojkowska W, Filipek S, Kowlaska A, Rossa G, Peplonska B, Styczynska M, Maruszak A, Religa D, Wender M, Kulczycki J, Barcikowska M, Kuznicki J (2006) Two novel presenilin 1 gene mutations connected with frontotemporal dementia-like clinical phenotype: genetic and bioinformatics assessment. Exp Neurol 200, 82-88.
29. Mehrabian S, Traykov LT, Jordanova A, Rademakers R, Cruts M, Raycheva MR, Van den Broeck M, Kremensky I, Van Broeckhaven C (2006) Novel PSEN1 gene mutation in a large Bulgarian pedigree with Alzheimer's disease and atypical phe- notype. Eur JNeurol 13 (suppl 2), 41.
30. Arai N, Kishino A, Takahashi Y, Morita D, Nakamura K, Yokoyama T, Watanabe T, Ida M, Goto J, Tsuji S (2008) Familial cases presenting very early onset autosomal dominant Alzheimer's disease with I143T in presenilin-1 gene: implication for genotype-phenotype correlation. Neurogenetics 9, 65-67.
31. Larner AJ, Ray PS, Doran M (2007) The R269H mutation in presenilin-1 presenting as late-onset autosomal dominant Alzheimer's disease. J Neurol Sci 252, 173-176.
32. Ikeda M, Yonemura K, Yoshida J, Fujita Y, Hashimoto Y, Ishiguro K, Oriuchi N, Harigaya Y, Okamoto K (2008) Diverse neurological symptoms presenting severe dementia, psy- chiatric symptoms and motor deficits in early-onset familial Alzheimer's disease. Alzheimers Dement 4 (suppl 2), T522.
33. Gomez-Tortosa E, Manzano S, Munoz DG, Sainz MJ, Jimenez-Huete A, Sagrario Barquero M, Baron M, Jimenez- Escrig A (2008) Clinical phenotype of familial Alzheimer's disease caused by the H163R presenilin 1 mutation. Alzheimers Dement 4 (suppl 2), T586.
34. Ikeda M, Yonemura K, Harigaya Y, Okamoto K (2006) Mutant presenilin-1 M233L presenting severe parkinsonism and common patterning of temporal processes in neurological symptoms. Alzheimers Dementia 2 (suppl 1), S255.
35. Mendez MF, McMurtray A (2006) Frontotemporal dementialike phenotypes associated with presenilin-1 mutations. Am J Alzheimers Dis Other Demen 21, 281-286.
36. Portet F, Dauvilliers Y, Campion D, Raux G, Hauw JJ, Lyon- Caen O, Carnu W, Touchon J (2003) Very early onser AD with a de novo mutation in the presenilin-1 gene (Met233Leu). Neurology 61, 1136-1137.
37. Santana I, Sá A, Guerreiro R, Bras J, Hardy J, Rogaeva E, Oliveira C (2006) Early onset familial Alzheimer's disease: first Portuguese cases. Alzheimers Dement 2(suppl 1), S199.
38. Mehrabian S, Traykov LD, Jordanova AK, Raycheva MR, Rademakers R, Cruts M, Van Broeckhaven C (2005) My- oclonus, as an atypical phenotype in familial early onset Alzheimer's disease. Epilepsia 46 (suppl 6), 283.
39. Alberici A, Bonato C, Borroni B, Cotelli M, Mattioli F, Binetti G, Gennarelli M, Luca MD, Simonati A, Perani D, Rossini P, Padovani A (2007) Dementia, delusions and seizures: storage disease or genetic AD? Eur J Neurol 14, 1057-1059.
40. de Bot ST, Kremer HPH, Dooijes D, Verbeek MM (2009) CSF studies facilitate DNA diagnosis in familial Alzheimer's disease due to a presenilin-1 mutation. J Alzheimers Dis 17, 53-57.
41. Kaufer DI, Yuen H, DeKosky ST, Klunk WE (2008) Cerebellar amyloid in a case of early-onset dementia with a presenilin-1 mutation: correlation to clinical phenotype. Alzheimers Dement 4 (suppl 2), T290-T291.
42. Murrell J, Ghetti B, Cochran E, Macias-Islas MA, Medina L, Varpetian A, Cummings JL, Mendez MF, Kawas C, Chui H, Ringman JM (2006) The A431E mutation in PSEN1 causing familial Alzheimer's disease originating in Jalisco State, Mexico: an additional fifteen families. Neurogenetics 7, 277-279.
43. Yescas P, Huertas-Vazquez A, Villarreal-Molina MT, Ras- mussen A, Tusie-Luna MT, Lopez M, Canizales-Quinteros S, Alonso ME (2006) Founder effect for the Ala431Glu mutation of the presenilin 1 gene causing early-onset Alzheimer's disease in Mexican families. Neurogenetics 7, 195-200.
44. Beck JA, Poulter M, Campbell TA, Uphill JB, Adamson G, Geddes JF, Revesz T, Davis MB, Wood NW, Collinge J, Tabrizi SJ (2004) Somatic and germline mosaicism in sporadic early- onset Alzheimer's disease. HumMol Genet 13, 1219-1224.
45. Lee P, Medina L, Ringman JM (2006) The Thr354Ile substitution in PSEN1: disease-causing mutation or polymorphism? Neurology 66, 1955-1956.
46. Pickering-Brown SM, Baker M, Gass J, Boeve BF, Loy CT, Brooks WS, Mackenzie IR, Martins RN, Kwok JB, Halliday GM, Kril J, Schofield PR, Mann DM, Hutton M (2006) Mutations in progranulin explain atypical phenotypes with variants in MAPT. Brain 129, 3124-3126.
47. Scacchi R, Gambina G, Moretto G, Corbo RM (2007) A mutation screening by DHPLC ofPSEN1 and APP genes reveals no significant variation associated with the sporadic late-onset form ofAlzheimer's disease. Neurosci Lett 418, 282-285.
48. Doran M, Larner AJ (2006) Familial Alzheimer's disease due to presenilin-1 Y115C mutation. JNeurol 253 (suppl 2), II91.
49. Leverenz JB, Fishel MA, Peskind ER, Montine TJ, Nochlin D, Steinbart E, Raskind MA, Schellenberg GD, Bird TD, Tsuang D (2006) Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype. Arch Neurol 63, 370-376.
50. Yokota O, Terada S, Ishizu H, Ujike H, Ishihara T, Nakashima H, Yasuda M, Kitamura Y, Ueda K, Checler F, Kuroda S (2002) NACP/alpha-synuclein, NAC, and beta-amyloid pathology of familial Alzheimer's disease with the E184D presenilin-1 mutation: aα clinicopathological study of two autopsy cases. Acta Neuropathol (Berl) 104, 637-648.
51. Bruni AC, Terni B, Bernardi L, Tomaino C, Maletta R, Smirne N, Calignano C, Paonessa A, Leotta A, Santo L, Puccio G, Colao R, Frangipane F, Curcio SAM, Mirabelli M, El Hachimi H, Foncin JF, Spillantini MG (2006) Genotype-phenotype relationship is lacking in families with PS1-Met146Leu founder mutation. Alzheimers Dement 2 (suppl 1), S431.
52. Shrimpton AE, Schelper RL, Linke RP, Hardy J, Crook R, Dickson DW, Ishizawa T, Davis RL (2007) A presenilin 1 mutation (L420R) in a family with early onset Alzheimer disease, seizures and cotton wool plaques, but not spastic paraparesis. Neuropathology 27, 228-232.
53. Vetrivel KS, Thinakaran G (2007) Presenilins. In Neurobiology of Alzheimer's disease (3rd ed.), Dawbarn D, Allen SJ, eds. Oxford University Press, Oxford, pp. 173-190.
54. Fang B, Jia L, Jia J (2006) Chinese presenilin-1 V97L mutation enhanced Abeta42 levels in SH-SY5Y neuroblastoma cells. Neurosci Lett 406, 33-37.
55. LarnerAJ (1999) Hypothesis: amyloid β-peptides truncated at the N-terminus contribute to the pathogenesis of Alzheimer's disease. Neurobiol Aging 20, 65-69.
56. Van Vickle GD, Esh CL, Kokjohn TA, Patton RL, Kalback WM, Luehrs DC, Beach TG, Newel AJ, Lopera F, Ghetti B, Vidal R, Castano EM, Roher AE (2008) Presenilin-1 280Glu- Ala mutation alters C-terminal APP processing yielding longer abetapeptides: implications forAlzheimer's disease. Mol Med 14, 184-194.
57. Larner AJ, Keynes RJ (2006) Neuroinhibitory molecules in Alzheimer's disease. JAlzheimers Dis 10, 75-80.
58. Pastor P, Roe CM, Villegas A, Bedoya G, Chakraverty S, Garcia G, Tirado V, Norton J, Rios S, Martinez M, Kosik KS, Lopera F, Goate AM (2003) Apolipoprotein E epsilon 4 modifies Alzheimer's disease onset in an E280A PS1 kindred. Ann Neurol 54, 163-169.
59. Lindquist SG, Holm IE, Schwartz M, Law I, Stokholm J, Bat- bayli M, Waldemar G, Nielsen JE (2008) Alzheimer diseaselike clinical phenotype in a family with FTDP-17 caused by a MAPT R406W mutation. Eur J Neurol 15, 377-385.
60. Doran M, du Plessis DG, Ghadiali EJ, Mann DMA, Pickering- Brown S, Larner AJ (2007) Familial early-onset dementia with tau intron 10 + 16 mutation with clinical features similar to those of Alzheimer disease. Arch Neurol 64, 1535-1539.
61. Larner AJ (2008) Mutation negative "early-onset familial Alzheimer's disease": consider screening for tau gene mutations. Alzheimer Dis Assoc Disord 22, 194-195.